Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ophtha.2017.11.021 | DOI Listing |
Dermatol Clin
January 2025
Department of Clinical Research, Center for Clinical Studies, LTD, Webster, TX 77598, USA; Department of Dermatology, The University of Texas Health Science Center at Houston, Bellaire, TX 77401, USA.
This comprehensive review article gives an up-to-date assessment of the therapeutic landscape for warts and molluscum contagiosum (MC), focusing on advances made in the last 5 years. New treatment choices include VP-102 (Ycanth) for molluscum contagiosum, potentially intralesional Vitamin D3 for warts, and topical cidofovir for both. Immunotherapy is regarded as a potential option, especially in difficult situations.
View Article and Find Full Text PDFInt Forum Allergy Rhinol
October 2024
Department of Dermatology, University of California, California, Irvine, USA.
Int Forum Allergy Rhinol
September 2024
Otorhinolaryngology department and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.
Rev Med Virol
September 2024
AP-HP, Centre National de Référence Herpèsvirus (Laboratoire Associé), Hôpital Pitié-Salpêtrière, Service de Virologie, and Sorbonne Université, INSERM, UMR-S 1136, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), Paris, France.
Herpes simplex virus (HSV) infections in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pose significant challenges, with higher incidence, severity, and risk of emergence of resistance to antivirals due to impaired T-cell mediated immunity. This literature review focuses on acyclovir-refractory/resistant HSV infections in HSCT recipients. The review addresses the efficacy of antiviral prophylaxis, the incidence of acyclovir-refractory/resistant HSV infections, and the identification of risk factors and potential prognostic impact associated with those infections.
View Article and Find Full Text PDFArch Dermatol Res
July 2024
Universidad Rey Juan Carlos, Madrid, Spain.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!